Introduction
Each year between 900 000 and 1 200 000 cases of nonmelanoma skin cancers (basal cell carcinomas and squamous cell carcinomas) are diagnosed in the United States (Buckman et al., 1998) . The major risk factor for skin cancer is excessive exposure to the ultraviolet (UV) component of sunlight which can be divided into three ranges: UVA (320 -400 nm), UVB (280 -320 nm) and UVC (200 -280 nm) (de Gruijl, 2000; Matsui and Deleo, 1991) . Since UVC and the majority of UVB radiation is absorbed by the ozone layer, most solar radiation (90 -99%) reaching the Earth's surface is UVA radiation (Matsui and DeLeo, 1991) .
UVA regulates the expression of various genes including heme oxygenase-1, matrix metalloproteinase-1, IL-1a/b, IL-6, intracellular adhesion molecule, STAT3, AP-1 and AP-2 (Basu- Modak and Tyrrell, 1993; Grether-Beck et al., 1996; Klotz et al., 1999; Maziere et al., 2001; Scharffetter-Kochanek et al., 1993; Wlaschek et al., 1997; Zhang et al., 2001b; Silvers and Bowden, 2002) . Considerable work is currently underway to elucidate the signal transduction mechanisms that are induced by UVA. UVA has been shown to activate signal transduction cascades such as Mitogen activator protein kinases (p38, ERK, JNK) and downstream kinases p90 RSK /MAPKAP-K1, and p70 S6K (Zhang et al., 2001a,d) . Signaling cascades involving cell survival proteins, including acid sphingomyelinase and ATM kinase have also been investigated recently (Zhang et al., 2001c (Zhang et al., , 2002 .
Alterations in gene expression associated with UV exposure play an important role in tumor promotion and progression. One example of such alterations involves the Cyclooxygenase-2 enzyme. There are two isoforms of the COX enzyme, also known as prostaglandin H synthase (PGHS). COX-1 is a 'housekeeping enzyme' that is constitutively expressed at low levels in most tissues. It regulates renal and vascular homeostasis and protects the stomach from ulcers (Prescott and Fitzpatrick, 2000) . In contrast, COX-2 is maintained at low levels in normal tissues and is induced by inflammatory cytokines, tumor promoters, growth factors and oncogenes (Prescott and Fitzpatrick, 2000) . The COX enzymes catalyze the oxidation of arachidonic acid when released from plasma membrane phospholipids upon activation of phospholipase A 2 (PLA 2 ), producing Prostaglandin G2 which is then further reduced to Prostaglandin H 2 .
Both UVA and UVB have been shown to activate PLA in human keratinocytes, causing arachidonic acid release (Gresham et al., 1996; Hanson and DeLeo, 1990 ; Kang-Rotondo et al., 1993). Elevation of Prostaglandin E 2 (PGE 2 ) levels are thought to play a role in carcinogenesis through inhibition of apoptosis, promotion of angiogenesis and increased cell proliferation (Fosslien, 2000; Sheng et al., 1998 Sheng et al., , 2000 Thompson et al., 2001; Tsujii et al., 1998) .
p38 is activated by phosphorylation at threonine and tyrosine residues by upstream kinases. The phosphorylation of p38 is then able to activate various substrates, including MAPK-activated protein kinase-2 (MAPKAPK-2). p38 MAPK has been shown to regulate COX-2 at both the transcriptional and posttranscriptional level. UVB-induced COX-2 expression was regulated by p38 at the transcriptional level in the human keratinocyte cell line, HaCaT Tang et al., 2001) . In IL-1-treated HeLa cells and lipopolysaccharide-treated primary human monocytes, inhibition of p38 activity resulted in destabilization of COX-2 messages, demonstrating the role of the p38 signaling cascade in the regulation of COX-2 stability (Dean et al., 1999; Lasa et al., 2000; Ridley et al., 1998) . Stability of COX-2 mRNA is regulated by adenylate and uridylate-rich elements (AREs) present in the 3' untranslated region (3' UTR) of the COX-2 message, and consists of 22 copies of the AUUUA sequence (Newton et al., 1997) . AREs in the 3' UTR normally target the transcript for rapid degradation. However, binding of RNA stability factors can extend the half-life of the message (Brennan and Steitz, 2001 ). HuR, a member of the Elav family of proteins, has been shown to bind to AREs present in the 3' UTR of COX-2 (Dixon et al., 2001; Nabors et al., 2001) . Thus, it appears that both the p38 signaling cascade and AREs that are present in the 3' UTR act to mediate the post-transcriptional regulation of COX-2.
Little is known about the expression of COX-2 and the mechanism by which it is regulated in response to UVA irradiation. Soriani et al. (1998) previously showed that UVA-induced COX-2 mRNA expression was decreased by epigallocatechin in the human oral carcinoma cell line KB but not in the human skin fibroblast cell line FEK4. Induction of COX-2 mRNA was also reported in response to solar simulated irradiation of human skin (Isoherranen et al., 1999) . At this time, however no study has addressed the role of the UVA spectrum alone in the expression of COX-2 in a model of nonmelanoma skin cancer. In this study, we examined the effects of UVA irradiation on COX-2 expression in the spontaneously immortalized human keratinocyte cell line, HaCaT. The HaCaT cell line contains a p53 mutational spectrum typical of UV-induced mutations and therefore serves as a particularly relevant model of non-melanoma skin cancer (Lehman et al., 1993) . We investigated message stabilization as one mechanism by which UVA regulates COX-2 expression and examined the role that the MAPK p38 plays in this process. From these studies, we conclude that p38 plays a critical role in the UVA-induced expression of COX-2 through message stabilization in these human keratinocytes.
Results
UVA caused a dose-dependent increase in COX-2 expression at both the protein and RNA levels
HaCaT cells were irradiated with increasing doses of UVA ranging from 200 -400 kJ/m 2 . Total cell protein was isolated and Western analysis was performed using a COX-2 specific antibody. As shown in Figure  1a , UVA caused an increase in COX-2 protein beginning at a dose of 250 kJ/m 2 and increasing with higher doses of UVA. No significant changes in COX-2 expression were observed in the mockirradiated cells. Two COX-2 bands were detected in the Western analysis. Since COX-2 has previously been reported to be post-translationally modified by a tyrosine phosphatase, the upper band could be a phosphorylated form of the enzyme (Parfenova et al., 1998) .
Northern analyses were also performed following UVA-irradiation using a [
32 P]-a-dCTP labeled human COX-2 cDNA probe (Oxford Biomedical Research). COX-2 message levels were also induced in a dosedependent manner (from 200 -400 kJ/m 2 ) in response to UVA (Figure 1b As shown in Figure 2a , 250 kJ/m 2 UVA induced detectable COX-2 protein between 2 and 8 h postirradiation, with peak expression at 4 h post-irradiation. No significant changes were observed in mockirradiated cells throughout the time course, with basal levels of COX-2 at very low expression levels. Figure  2b shows the expression patterns of COX-2 at the RNA level in response to 250 kJ/m 2 UVA. Increased COX-2 RNA levels were detectable at 1 and 2 h postirradiation. At time points beyond 2 h, COX-2 message was no longer detectable by Northern analyses. Two major transcripts of COX-2 (2.7 and 4.1 kb) have been reported and are the result of alternative polyadenylation sites (Appleby et al., 1994; Gou et al., 1998; Newton et al., 1997) . Induction of the 4.1 kb transcript was observed in response to UVA irradiation. No changes were observed in the 2.7 kb transcript in mock-irradiated or in UVA-irradiated cells. In repeated experiments, COX-2 expression levels were examined up to 8 h with no changes between mock-irradiated and irradiated cells (data not shown).
UVA-induced p38 activity
Previous studies have reported that p38 is activated in response to UVA irradiation in NCTC 2544 human keratinocytes and in human skin fibroblasts from foreskin biopsies (Klotz et al., 1999; Maziere et al., 2001) . As shown in Figure 3a , phosphorylated p38 levels were also induced by UVA in the HaCaT cell line between 30 and 90 min post-irradiation. Total levels of p38 were detected as a loading control. A specific inhibitor of p38, SB202190, was used to inhibit p38 phosphorylation of a downstream target, MAPKAPK2. SB202190 acts by binding reversibly to the ATP-binding pocket of p38, preventing phosphorylation and subsequent activation of downstream substrates. Figure 3b shows an in vivo activity assay to demonstrate that the SB202190 compound was indeed inhibiting p38 activity. As expected, at time points where p38 is strongly activated (30 and 45 min post-irradiation), MAPKAPK2 is predominantly phosphorylated (upper band). In mock-irradiated cells both phosphorylated and unphosphorylated (lower band) forms were detectable. In UVA-irradiated samples with SB202190 treatment, an increase in the unphosphorylated form of MAPKAPK2 was observed. This confirms that p38 was indeed active in response to UVA and that its activity was effectively inhibited with SB202190 treatment.
Inhibition of p38 by SB202190 decreased both UVAinduced COX-2 protein and RNA levels
To determine if p38 plays a role in UVA-induced COX-2 expression, we used SB202190 in varying concentrations and examined COX-2 RNA and protein levels. Figure 4a shows that with increasing concentrations of SB202190 (1.0 -2.0 mM), COX-2 message levels decreased in a dose-dependent manner. Quantitation of the expression level of COX-2 normalized to GAPDH expression is presented in Figure 4b . A dose of 2 mM SB202190 decreased COX-2 message levels to 54% of HaCaT cells were grown to 90% confluence in complete DMEM, serumstarved for 24 h, and then irradiated with 250 kJ/m 2 . Control cells were mock-irradiated. (a) Total cell protein was isolated at various time points following irradiation. Western analysis was performed using phospho-specific antibodies to p38 (New England Biolabs, Inc.). Total levels of p38 were also detected as a loading control (New England Biolabs, Inc.). (b) HaCaT cells were treated with 2 mM SB202190 for 1 h prior to UVA irradiation (250 kJ/ m 2 ). Cells were then placed in serum-free DMEM containing SB202190 and collected at 15, 30, 45, 60 and 90 min post-irradiation and Western analysis was performed using a MAPKAPK-2 antibody (Santa Cruz). 7, mock-irradiated; +, UVA-irradiated, SB202190, p38 inhibitor that of irradiated cells with no treatment. Treatment of the HaCaT cells with SB202190 also abrogated COX-2 at the protein level (Figure 4c) . A small change in basal levels is observed in mock-irradiated cells with SB202190 treatment, however this effect was not reproduced in repeated experiments.
COX-2 mRNA is stabilized by p38 in response to UVA Semi-quantitative RT -PCR was used to determine the half-life of the COX-2 message in UVA-irradiated and mock-irradiated cells. Basal levels of COX-2 were below detectable levels in mock-irradiated cells and therefore could not be accurately quantified by Northern blot analysis. Figure 5 shows that in mockirradiated cells, the COX-2 message was decreased between 30 min and 2 h. The half-life of the message was determined to be between 30 and 60 min through quantitation (data not shown). In contrast, UVAirradiated cells had an extended COX-2 message halflife between 4 and 8 h post-UVA irradiation. In UVAirradiated samples, levels of COX-2 message were induced and had a half-life more than four times that observed in mock-irradiated cells. To show that p38 was responsible for the stabilization of the COX-2 message in UVA-irradiated cells, we again treated the HaCaT cells with SB202190. By inhibiting p38 activity in UVA-irradiated cells, the half-life of the COX-2 message was reduced to that observed in mockirradiated cells.
Dominant-negative p38 inhibited luciferase expression through the 3' UTR of COX-2 A luciferase expression vector was generated to examine the effects of COX-2 expression mediated through the 3' UTR. The 3' UTR of COX-2 was inserted immediately downstream of the Renilla reporter coding sequence. Figure 6 shows a significant increase (* denotes P50.05) in luciferase activity in UVA-irradiated cells (250 kJ/m 2 ) transfected with the 3' UTR of COX-2 (pRL-TK+3' UTR) compared to the parental vector (pRL-TK). No significant change was observed in mock-irradiated cells transfected with the parental vector or 3' UTR of COX-2. In UVAirradiated cells transfected with the 3' UTR of COX-2, however, the level of luciferase activity is approximately 1.5-fold greater than that of the mockirradiated cells.
When a dominant-negative p38 construct is cotransfected with the 3' UTR reporter construct, no difference is observed between mock-irradiated and UVA-irradiated samples. The dominant-negative form of p38 MAPK expressed by this construct contains a a b c Figure 4 Effect of SB202190 on COX-2 RNA expression. HaCaT cells were grown to 90% confluence, serum-starved for 24 h, and irradiated with 250 kJ/m 2 . Control cells were mock-irradiated. (a) Cells were treated with doses of SB202190 ranging from 1.0 -2.0 mM for 1 h prior to 250 kJ/m 2 UVA irradiation, post-treated with SB202190 for 1 h and then harvested for Northern analysis. (b) Quantification of COX-2 expression was normalized to GAPDH for each treatment using ImageQuant from Molecular Dynamics. (c) Cells were pre-treated with 2 mM SB202190 for 1 h prior to UVA-irradiation. Cells were also treated with SB202190 following irradiation and total protein collected at 2 and 4 h for Western analysis using a COX-2 antibody (Santa Cruz). 7, mock-irradiated; +, UVA-irradiated; SB202190, p38 inhibitor Figure 5 Half-life of COX-2 message following UVA-irradiation. HaCaT cells were grown to 90% confluence, serum-starved for 24 h, and irradiated with 250 kJ/m 2 . Control cells were mockirradiated. Cells treated with 2 mM SB202190 were pre-and post-treated as described previously. Following UVA-irradiation, cells were treated with Actinomycin D (1 mg/ml) for 1 h. Total RNA was isolated and reverse transcribed into cDNA using Omniscript (Qiagen). COX-2 and GAPDH cDNAs were co-amplified by PCR within a pre-determined linear range to allow a quantifiable analysis of the products, 7, mock-irradiated; +, UVA-irradiated; SB202190, p38 inhibitor double point mutation of Thr-Gly-Tyr to Ala-Gly-Phe at the sites of activating phosphorylation (Threonine 180 and Tyrosine 182). These data demonstrate that blocking p38 signaling using a dominant-negative construct completely abrogated increases in luciferase activity mediated through the 3' UTR in UVAirradiated cells. We conclude, therefore, that p38 plays a role in the post-transcriptional regulation of COX-2 through the 3' UTR. Additionally, these studies confirm the message about half-life studies presented in Figure 5 using a p38 dominant-negative construct.
Discussion
In this study, we show that UVA induced COX-2 expression in the human keratinocyte cell line, HaCaT, and provide evidence for regulation at the posttranscriptional level. COX-2 expression was upregulated in response to UVA at the protein and mRNA levels. In addition, p38 activity was shown to be necessary for this UVA-induced upregulation. Using the specific inhibitor SB202190, we demonstrated that p38 activity mediates the stabilization of COX-2 mRNA in response to UVA irradiation.
Other investigations have described similar mechanisms of COX-2 message stabilization mediated by p38 in response to other stimuli, such as Lipopolysaccharide, IL-1 and oncogenic Ras (Dean et al., 1999; Lasa et al., 2000; Ridley et al., 1998; Zhang et al., 2000) . p38 has been shown to be involved in the stabilization of other genes as well, including IL-8 and IL-6 (Winzen et al., 1999) . Modulation of RNA degradation through AU-rich elements present in the 3' UTR is an important means of regulating gene expression, especially for those genes involved in inflammation, as it can provide a very rapid response to stimuli without the need for transcriptional activity (Chen and Shyu, 1995) . It has been clearly demonstrated that a 116-nucleotide region of the COX-2 3' UTR (containing the majority of the AU-rich elements present in the transcript) are responsible for mRNA degradation (Cok and Morrison, 2001; Dixon et al., 2000) . AUrich elements normally mediate a rapid turnover of RNA, acting as a destabilizing element and decreasing translational efficiency. Trans-acting factors, such as HuR, have been shown to bind and stabilize COX-2 RNA, resulting in elevated expression in other model systems (Dixon et al., 2001; Nabors et al., 2001) . The two transcript sizes of COX-2 are the result of alternative polyadenylation (Appleby et al., 1994; Gou et al., 1998; Newton et al., 1997) . Larger transcripts contain a greater number of AREs and, therefore, may be regulated at the post-transcriptional level. In the Northern analysis of COX-2 expression in response to UVA, induction of the 4.1 kb transcript can be seen. However, no change was observed in the 2.7 kb transcript between irradiated and mock-irradiated cells. This provides further support for the data presented here that COX-2 is regulated at the posttranscriptional level. Finally, luciferase reporter constructs containing the 3' UTR of COX-2 directly address the involvement of the 3' UTR and the role of p38 in UVA-induced COX-2 expression.
The primary focus of previous investigations concerning UV light and COX-2 expression has been the UVB spectrum and its effect upon gene expression. Tang et al. (2001) showed that UVB induced COX-2 expression in HaCaT cells through p38 activation. While message stabilization was not investigated as the primary mechanism of regulation in the study, the cyclic-AMP response element was shown to be a critical component of COX-2 regulation at the transcriptional level. Treatment with SB202190 significantly decreased message and protein levels of COX-2 in response to UVB . Hanson and DeLeo (1990) showed that UVA induces Phospholipase A 2 activity in human epidermal keratinocytes and increases cyclooxygenase activity in human fibroblasts (Hanson and DeLeo, 1989; Soriani et al., 1998) . Since UVA is the primary component of solar radiation reaching the surface of the Earth, its effects on gene expression, particularly those involved in tumor progression like COX-2, remain of particular interest.
Several investigators have addressed the importance of COX-2 in skin tumor promotion. A selective inhibitor of COX-2, Celecoxib, reduced the tumor yield by 89% in a dose-dependent manner in UVBirradiated hairless mice (Fischer et al., 1999; Thompson et al., 2001 ). In the same study, Indomethacin, a nonspecific COX-2 inhibitor, also showed a significant reduction (78%) in tumor number in UVB-irradiated mice (Fischer et al., 1999) . PGE 2 has been shown to regulate the growth of human keratinocytes in vitro (Pentland and Needleman, 1986). Increased levels of Figure 6 Effect of p38 signaling and the 3' UTR of COX-2 on luciferase expression. HaCaT cells were grown to 95% confluence and transfected with the pRL-TK Renilla or pRL-TK+3' UTR of COX-2 with pCMV5 (the empty vector of p38 DNM construct) or with a p38 DNM construct. The transfection was performed for 6 h in serum free DMEM, followed by an additional 18 h incubation in serum free DMEM prior to UVA irradiation (250 kJ/m 2 ). Total cellular protein was collected 4 h post-irradiation and luciferase activity was measured. Columns, average; bars, s.e.m.; n=3. * indicates P50.05 compared to the mock-irradiated group transfected with pRL-TK+3' UTR PGE 2 have been described in basal cell carcinomas with an aggressive growth pattern (Vanderveen et al., 1986) . Inhibitors of prostaglandin production and their ability to inhibit tumor growth and metastasis provide evidence for the role of prostaglandins in tumorigenesis (Buckman et al., 1998; Hial et al., 1976; Lynch et al., 1978; Snyderman et al., 1995) . These studies demonstrate the possible role that COX-2 plays in the promotion of skin tumors and illustrate the need for inhibitors of COX-2.
In conclusion, we have shown for the first time that UVA-induced expression of COX-2 is post-transcriptionally regulated by p38 through message stabilization. Modulation of p38, therefore, is a potential molecular target for the chemoprevention of skin cancer and may serve as an alternative to specific COX-2 inhibitors.
Materials and methods

Cells and UVA treatment
HaCaT cells, a spontaneously immortalized human keratinocyte cell line, were cultured in DMEM supplemented with 10% fetal bovine serum and 100 u/ml of penicillin/streptomycin. They were grown to 90% confluence and placed in serum free DMEM for 24 h. Cells were placed in PBS supplemented with 0.01% MgCl 2 and 0.01% CaCl 2 for the duration of irradiation. Control cells were mock-irradiated in supplemented PBS in a separate tissue culture hood. A bank of four F20T12/BL/HO PUVA bulbs (National Biological Corporation, Twinsburg, OH, USA), providing a peak emission at 365 nm, was used. For experiments with SB202190 treatment, cells were treated for 1 h prior to irradiation and treated after UVA irradiation until the cells were harvested. In experiments analysing COX-2 message half-life, transcription was inhibited by treatment with Actinomycin D (1 mg/ml) for 1 h after irradiation in serumfree DMEM.
Luciferase reporter construction
The 3' UTR of COX-2 was inserted into the XbaI site of the expression vector pRL-TK Renilla luciferase (Promega, Madison, WI, USA), the region adjacent to the coding sequence, to yield pRL-TK+3' UTR. The original 3' UTR region of COX-2 was obtained from a plasmid received from Dr Stephen Prescott (Hunstman Cancer Institute, University of Utah, Salt Lake City, UT, USA). The portion of the 3' UTR cloned into the pRL-TK vector correspond to base pairs 1913-3387 of COX-2 (GenBank Accession Number M90100). The DNA construct was analysed by restriction mapping and DNA sequencing.
The p38 DNM construct was obtained from Dr Zigang Dong (Hormel Institute, University of Minnesota, Austin, MN, USA). The plasmid expresses a dominant-negative form of p38 MAPK containing a double point mutation of ThrGly-Tyr to Ala-Gly-Phe at the sites of activating phosphorylation (Threonine 180 and Tyrosine 182). A control vector (PCMV5) was generated through a ClaI/XbaI digest to remove the p38 dominant negative insert. The overhangs generated were filled in using the large fragment of DNA Polymerase I (Invitrogen, Carlsbad, CA, USA) and ligated using T4 ligase (Invitrogen, Carlsbad, CA, USA).
Transient transfections
HaCaT cells were transiently transfected using Lipofectamine PLUS (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. Briefly, cells were plated in 35 mm dishes the day before transfection and grown to 95% confluence. Plasmid DNA was prepared in 100 ml serum free DMEM and incubated with 3 ml of PLUS reagent at room temperature for 15 min, followed by 2.5 ml of Lipofectamine in an additional 100 ml DMEM. The mixture was incubated for another 15 min and then added to the well containing 1 ml of serum free DMEM. Transfections were allowed to proceed for 6 h. A total of 0.4 mg of DNA was used for transfection into each well (0.2 mg of pRL-TK or pRL-TK+3' UTR and 0.2 mg of PCMV5 or 0.2 mg of p38 DNM). The cells were then washed twice with serum free DMEM and incubated for an additional 18 h in DMEM before UVA treatment.
Luciferase assay
After treatments, cells were washed twice with PBS and total protein was extracted in lysis buffer (15 mM MgSO4, 25 mM glycylglycine, 4mM ethylene glycol-bis(b-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA), 1% vol/vol Triton X-100, 1 mM dithiothreitol (DTT). All treatments were done in triplicate for each experiment. The luciferase activity of 20 mg total cellular protein was measured using the TD-20/20 luminometer (Turner Designs, Sunnydale, CA, USA).
Total cellular protein extraction and Western analysis
Cells were lysed in 20 mM Tris-HCl (pH=7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM Na 4 P 2 O 7 , 1 mM b-glycerophosphate, 1 mM Na 3 VO 4 , and 1 mg/ml leupeptin. Cells were scraped and centrifuged at 14 000 r.p.m. for 5 min. Protein concentration was determined using Bio-Rad D c reagent (Bio-Rad Laboratories, Hercules, CA, USA). For Western analysis, 40 mg of protein were resolved on a 12.5% SDS-polyacrylamide gel. The protein was then transferred to a polyvinylidene difluoride membrane overnight at 48C. The membrane was then blocked with 5% milk in TBST at room temperature for 1 h. Primary antibodies for COX-2 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and total p38 (New England Biolabs, Inc., Beverly, MA, USA) were used at 1 : 3500 dilution and 1 : 1000 dilution, respectively, and incubated in 5% milk at room temperature for 2 h. Primary antibody for phospho-p38 (New England Biolabs, Inc., Beverly, MA, USA) was used at 1 : 1000 dilution and incubated at 48C overnight. The membrane was incubated with the appropriate horseradish-peroxidase secondary antibody in 5% milk/TBST for 1 h at room temperature. Bovine anti-goat secondary (Santa Cruz Biotechnology, Santa Cruz, CA, USA) was used at a 1 : 3500 dilution for COX-2 Westerns and anti-rabbit secondary (New England Biolabs, Inc., Beverly, MA, USA) was used for phospho-p38 and total p38 at a dilution of 1 : 2000. Membranes were washed three times for 10 min each in TBST between antibody incubations and were detected using ECL Western blotting detection reagents (Amersham Pharmacia Biotech, Piscataway, NJ, USA).
In vivo p38 activity assay
The in vivo p38 activity assay was performed as previously described (Chen and Bowden, 1999) . 10 mg of total cell lysate was resolved on a 12.5% SDS-polyacrylamide gel overnight at 48C. Protein was transferred to a polyvinylidene difluoride membrane for 6 h at 48C. The membrane was blocked in 5% BSA in TBST for 1 h at room temperature and incubated with MAPKAPK2 antibody at 1 : 1000 dilution (Santa Cruz Biotechnology, Santa Cruz, CA, USA) overnight at 48C in 5% BSA in TBST. Horseradish-peroxidase conjugated secondary antibody was added at 1 : 100 000 dilution for 1 h at room temperature. Membranes were washed three times for 10 min each in TBST between antibody incubations and were detected using ECL Western blotting detection reagents (Amersham Pharmacia Biotech, Piscataway, NJ, USA). This assay allowed the phosphorylated and unphosphorylated forms of MAPKAPK2 to be detected.
Northern analysis
Total RNA was isolated using the RNeasy Mini kit from Qiagen (Valencia, CA, USA). 30 -40 mg of total RNA were electrophoresed on a 1.2% agarose gel containing formaldehyde. RNA was then transferred to GeneScreen nylon membrane from NEN (Boston, MA, USA) using PosiBlot 30-30 Pressure Blotter from Stratagene (Cedar Creek, TX, USA). Membranes were hybridized with a [
32 P]-a-dCTP human COX-2 cDNA probe overnight at 428C (Oxford Biomedical Research, Oxford, MI, USA). A GAPDH probe, which was generated from a 0.75 kb Pst-XbaI fragment of human GAPDH cDNA from the PTZ-GAP plasmid, was used as a loading control. Membranes were washed twice with 26SSC/0.1% SDS at room temperature, twice at 428C with 26SSC/0.1% SDS and twice at 658C with 0.16SSC/ 0.1% SDS. Northern blots were visualized and quantitated using a phosphorimager (Molecular Dynamics, Sunnyvale, CA, USA).
Semi-quantitative RT -PCR
Total RNA was isolated using the RNeasy Mini kit (Qiagen, Valencia, CA, USA). Total RNA (2 mg) was reverse transcribed into cDNA using the Omniscript Reverse Transcriptase kit (Qiagen, Valencia, CA, USA). The primers for PCR were end-labeled with [ 32 P]g-ATP using T4 polynucleotide kinase from Invitrogen (Carlsbad, CA, USA) according to the manufacturer's protocol. The cDNA was amplified for twenty-five cycles of PCR (948C for 45 s, 558C for 30 s, 728C for 90 s, and extension for 10 min at 728C). COX-2 primers used were 5'-CGA GGT GTA TGT ATG AGT GTG-3' and 5'-TCT AGC CAG AGT TTC ACC GTA-3' (Hla and Neilson, 1992; Subbarayan et al., 2001) , which generated a 590 bp product. GAPDH primers used were 5'-CTC ATG ACC ACA GTC CAT GC-3' and 5'-TGA CAA AGT GGT CGT TGA GG-3', which generated a 405 bp product. PCR products were electrophoresed on an 8% Acrylamide/Urea gel (50% Urea, 56TBE) and visualized using a phosphorimager (Molecular Dynamics, Sunnyvale, CA, USA). Quantifiction of the products was performed using the ImageQuant program from Molecular Dynamics.
Abbreviations UVA, ultraviolet A; UVB, ultraviolet B; UVC, ultraviolet C; COX-1, cyclooxygenase-1; COX-2, cyclooxygenase-2; MAP, mitogen-activated protein; p38, p38 MAP kinase; MAP-KAPK2, MAP kinase activated protein kinase 2; AREs, adenylate and uridylate-rich elements; 3' UTR, 3'; untranslated region
